|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rapid Report |
1 Biomedical Science, University of Sheffield, Sheffield S10 2TN, UK
2 Institute of Membrane and Systems Biology, University of Leeds, Leeds LS2 9JT, UK
3 Department of Pharmacology, Penn State College of Medicine, Hershey, PA 17033, USA
| Abstract |
|---|
|
|
|---|
(Received 2 December 2005;
accepted after revision 2 February 2006;
first published online 9 February 2006)
Corresponding author D. J. Beech: Institute of Membrane and Systems Biology, Garstang Building, University of Leeds, Leeds LS2 9JT, UK. Email: d.j.beech{at}leeds.ac.uk
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
Tetracycline-inducible expression of human TRPC5 (Zeng et al. 2004) and human FLAG-epitope-tagged TRPM2 (McHugh et al. 2003) in HEK293 cells has been described. Cells were grown in Dulbecco's modified Eagle's mediumF12 (Invitrogen) supplemented with 10% fetal bovine serum and penicillin (50 units ml1) and streptomycin (0.5 mg ml1) at 37°C in a 5% CO2 incubator. One microgram of wild-type (WT) or dominant negative (DN) mutant (E120Q) NCS-1 in the pcDNA3() plasmid was transfected into cells using the Fugene 6 transfection reagent (Roche, Lewes, UK). The fluorescent protein plasmid pDsRed2-N1 (0.1 µg) (Clontech, Palo Alto, CA, USA) was cotransfected to act as an indicator of transfection. PC12 cells were obtained from the European collection of cell cultures (ECACC no. 88022401) and cultured according to the instructions supplied. Cells were plated on collagen type IV-coated coverslips placed in 12-well plates. Cells were transfected with the cDNAs using lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. DNTRPC5 is a triple alanine mutation of the conserved LFW sequence in the ion pore; dominant negative function was demonstrated previously (Strubing et al. 2003) and confirmed by us in the HEK-TRPC5 cells (data not shown). We obtained PC12 cell transfection efficiency up to 70%. NGF (Invitrogen) was added at 50 ng ml1 after 2 days. Western blot analysis confirmed successful over-expression of all transfected plasmids. The cells were allowed to differentiate in the presence of NGF for 3 days and a more neuronal phenotype could be seen (i.e. neurite formation) before fixing for immunocytochemistry. Anti-NCS-1 (rabbit) (Biomol/Affiniti, Exeter, UK) or affinity purified anti-Frequenin (chicken) (Rockland Immunochemicals) was used at 1 : 1000 for overexpression and at 1 : 500 to detect endogenously expressed NCS-1. TUJ1 neuronal class III ß-tubulin monoclonal (Covance) was used at 1 : 500.
Reverse transcriptase-PCR (RT-PCR)
Total RNA was extracted from PC12 cells using the RNeasy kit (Qiagen) and subjected to oligo(dT)-primed reverse transciption. Rat TRPC5 PCR primers were (5'3'): forward, ACCTCTCATCAGAACCATGCCA; reverse TGCATGAGCAAGTCACAGGCCT. Rat TRPC4 primers were (5'3'): forward, TCTGCAGATATCTCTGGGAAGAATGC; reverse, AAGCTTTGTTCGAGCAAATTTCCACTC. PCR was 94°C for 2 min followed by 35 cycles of 94°C (30 s), 60°C (30 s), 72°C (30 s), and finally 72°C for 7 min.
Image analysis and neurite outgrowth quantification
Representative PC12 cell images were picked blind at random for each experimental group from at least three separate transfections performed on different days. The numbers of neurites were counted per cell and neurite length was measured directly from the cell body to the end of the neurite. We analysed 40 cells for each transfected plasmid and the averaged values as mean ±S.E.M. were graphed and compared to control cells transfected with vector (pcDNA3.1 ()) alone.
Immunoprecipitation and Western blotting
Thirty-six hours after induction of TRex-TRPC5 or TRex-TRPM2 cells with tetracycline (1 µg ml1), the cells were washed 3 times in chilled phosphate-buffered saline (PBS), harvested by scraping, and centrifuged for 5 min at 500 g. If the cells were not used immediately, the cell pellet was snap frozen in liquid N2 and stored at 80°C. Cells were homogenized at 4°C in ice-cold lysis buffer containing (mM): Trisacetate 20, pH 7; EDTA 1, sodium ß-glycerophosphate 10, sodium orthovanadate 1, Triton X-100 1%, sucrose 270, protease inhibitor tablet (Roche), benzamidine 1 and ß-mercaptoethanol 0.1%. Rats (> postnatal day 12) were killed by cervical dislocation according to Schedule 1 procedures outlined in the Code of Practice, UK Animals (Scientific Procedures) Act 1986. Rat brain membranes were isolated with an additional ultracentrifugation step. The membrane lysates were centrifuged at 4°C in a microcentrifuge and the protein concentration of the supernatants assayed by the Bradford method using BSA as a standard. For immunoprecipitation experiments, 600 µg of lysate was precleared with protein GSepharose agarose (Amersham Biosciences, UK) by incubating for 1 h at 4°C on a rotating mixer. To 500 µg of precleared cell/brain lysate was added 4 µg anti-NCS-1 for 2 h. Immune complexes were recovered by the addition of 30 µl of protein GSepharose agarose with further mixing overnight at 4°C. The tubes were briefly centrifuged and the pelleted protein-G immune complex was boiled for 5 min after adding 50 µl of sample buffer (Sigma, UK). The tubes were spun once more and 25 µl of the supernatant was resolved by 10% SDS-PAGE and transferred to nitrocellulose membrane. Membranes were blocked in PBS 1 x with 0.1% TWEEN and 3% milk powder prior to incubation for 1 h with primary antibodies. Anti-TRPC5 antibodies were a custom-made, affinity-purified antibody generated in chicken (to peptide VFETWGEACDLLMHKWGDGQ) or a commercial antibody generated in rabbit (Sigma, UK). Monoclonal anti-FLAG M2 antibody was from Sigma. Blots were incubated with the appropriate secondary antibody coupled to horseradish peroxidase before being washed 3 times in PBS followed by ECL detection.
Biotinylation experiments
A Cell Surface Protein Biotinylation and Purification Kit (Pierce) was used according to the manufacturer's instructions. Briefly PC12 cells overexpressing TRPC5 in combination with DN or WT NCS-1 were labelled with Sulfo-NHS-SS-Biotin. Cells were lysed and Bradford assays were used to determine the same amount of EZ-link sulfo-NHS-SS-biotin labelled protein for binding to the immobilized NeutrAvidin gel, bounds proteins were released by incubating with sample buffer, equal amounts were run on 10% SDS-PAGE and subjected to Western blot analysis with anti-TRPC5 to look for changes in surface expression.
Directed yeast two-hybrid screen
Constructs were generated by PCR amplification and verified by DNA sequencing. A cDNA encoding the complete NCS-1 (accession no. NM_014286) open reading frame (ORF) was constructed in the DNA-binding domain vector pAS2-1 (BD Biosciences Clontech) and used as bait. cDNAs encoding carboxyl-terminal truncations of human TRPC5 (accession no. AF054568) were constructed in the DNA-activation domain vector pACT2 (BD Biosciences Clontech) and separately used as prey. Bait and prey constructs were sequentially transformed into yeast strain MaV103 using a lithium acetate protocol (Lin, 2001). Transformants were identified via growth on Leu/Trp selection plates. Proteinprotein interactions were detected using
-galactosidase assays according to the manufacturer's instructions (BD Biosciences). Positive interactions were identified by growth of yeast on selection plates (Leu/Trp) and expression of
-galactosidase activity by cleavage of 5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside (X-
-gal; Calbiochem).
GST-pulldown
A cDNA encoding the complete NCS-1 ORF was constructed in pGEX-4T-1 (Amersham Pharmacia) to generate GST-tagged NCS-1 (NCS-1-GST). The third cytoplasmic loop of the dopamine D2L receptor (amino acids 211373) was constructed in pGEX-4T-1 to generate a GST-tagged D2L receptor (D2LIC3-GST) and was used as a negative control. Carboxyl-terminal truncations of hTRPC5 were subcloned in the vector pET30C (Novagen) to generate a set of S-tagged constructs. All fusion proteins were induced in E. coli strain BL-21 (DE3) and purified using glutathione-Sepharose beads (Amersham) according to the manufacturer's instructions. Eluted proteins were separated by SDS-PAGE and transferred to a polyvinylidene difluoride (PVDF) membrane. The membrane was probed for the presence of S-tagged carboxyl-terminal hTRPC5 fusion proteins using an anti-S-tag polycolonal antibody (1 : 5000 dilution) conjugated to horseradish peroxidase (Novagen). Immunoreactivity was detected by ECL.
Ca2+ imaging and patch-clamp recording
Experiments were performed as previously described (Zeng et al. 2004). The standard bath solution contained (mM): NaCl 130, KCl 5, D-glucose 8, Hepes 10, MgCl2 1.2, CaCl2 1.5; pH was titrated to 7.4 with NaOH. The patch pipette solution contained (mM): CsCl 100, Hepes 10, Na2ATP 5, EGTA 10, MgCl2 2; CaCl2 was included at 0 (0 nM), 4.3 mM (100 nM), 6.9 mM (300 nM), 8.173 mM (600 nM) and 8.84 mM (1000 nM) to obtain the unbound Ca2+ concentrations in parentheses after titration to pH 7.2 and adjustment of osmolarity to 290 mosmol l1 with mannitol. Unbound Ca2+ concentrations were calculated using EQCAL software (Biosoft, Cambridge, UK). Standard bath solution was used for all recordings (see Ca2+ imaging). 2-Aminoethoxydiphenyl borate (2-APB, Sigma) was prepared as a 75-mM stock in 100% dimethylsulphoxide.
Data analysis
Averaged data are given as means ±S.E.M. Statistical analysis was by paired or unpaired Student's t test, as appropriate (*P < 0.05; **P
0.001; n.d. denotes not different).
| Results |
|---|
|
|
|---|
|
|
TRPC5 shows modest activation in response to 200 nM intracellular Ca2+ (Ca2+i) (Strubing et al. 2001; Zeng et al. 2004), which is in the range of NCS-1's Ca2+-binding affinity (Burgoyne & Weiss, 2001). Activation of TRPC5 by other means also depends on intracellular Ca2+: for example, activation by gadolinium is graded according to Ca2+i (Fig. 2D) and fails when Ca2+i is buffered to very low levels by EGTA (Supplemental material, Fig S2). These observations suggest that TRPC5 function has a general dependence on physiological Ca2+i as if Ca2+ has a permissive role. We therefore explored the hypothesis that the function of TRPC5 depends on the Ca2+-sensing capability of NCS-1. In order to buffer Ca2+i at specific concentrations we performed whole-cell patch-clamp recordings, controlling Ca2+ via the patch pipette. DNNCS-1 inhibits TRPC5 current when Ca2+ in the patch pipette is 300 or 600 nM but has weak effects outside this Ca2+ range (Fig. 2D). These data are consistent with NCS-1 acting as a sensor underlying Ca2+ dependence of TRPC5.
To determine if NCS-1 acts as a direct Ca2+ sensor for TRPC5 we investigated whether there is physical association between the two proteins. In TRPC5 over-expressing cells, TRPC5 occurs in the precipitate pulled down by anti-NCS-1 antibody (Fig. 3A). Similarly, anti-NCS-1 antibody pulls-down endogenous TRPC5 in rat brain (Fig. 3B). These data demonstrate that NCS-1 and TRPC5 exist in the same protein complex. NCS-1 specificity was suggested by the failure of anti-NCS-1 antibody to pull down another Ca2+-dependent TRP channel, TRPM2 (Supplemental material, Fig S3). To test for a direct interaction between NCS-1 and TRPC5 we performed yeast two-hybrid assays, focusing on the C-terminus of TRPC5. A positive interaction was detected in eight independent experiments (Fig. 3C). In control experiments we failed to detect an interaction between NCS-1 and protein 4.1N (data not shown). In order to better define the NCS-1 interaction site, truncated fragments of TRPC5 C-terminus were tested; the data suggest predominant interaction with proximal C-terminus but do not exclude other regions (Fig. 3C). As an independent test of these findings, in vitro GST pull-down assays were performed (Fig. 3D). The entire C-terminal fragment (619973) exhibited binding to the D2L dopamine receptor, which had been included as a negative control. However, proximal and distal TRPC5 C-terminal fragments showed specificity failing to bind D2L but showing robust interaction with NCS-1 (Fig. 3D). Collectively the data suggest NCS-1 is a direct protein partner of TRPC5.
|
| Discussion |
|---|
|
|
|---|
There are seven TRPC family members, with six being expressed in human. Based on analogies with the structurally related voltage-gated potassium channels it is thought four TRP proteins come together to form a single channel, often involving mixtures of different TRP subtypes. TRPC5, for example, interacts with TRPC1 (Strubing et al. 2001). However, TRPC1 was not detected in neuronal growth cones (Greka et al. 2003) implying TRPC5 exists as a homotetramer in this context. The other possible partner is the functionally similar TRPC4 (Plant & Schaefer, 2003), although we have not been able to detect RNA-encoding TRPC4 in PC12 cells (see Supplemental material, Fig S1b).
We suggest TRPC5 and NCS-1 form a direct and functional protein partnership, with NCS-1 having a positive impact on TRPC5 and thus Ca2+ influx. It is envisaged that NCS-1 mediates the permissive role of intracellular Ca2+ on TRPC5 function, regulating the capacity of TRPC5 to respond to activators with high efficacy. Although positive with regard to Ca2+ influx, this partnership is inhibitory for neurite outgrowth, consistent with previous but independent reports for TRPC5 and NCS-1 (Angaut-Petit et al. 1998; Greka et al. 2003; Bezzerides et al. 2004). Optimal ranges of Ca2+ are required for neuronal outgrowth with differential actions of Ca2+ on neurite extension (Henley & Poo, 2004; Bolsover, 2005). Synaptic plasticity is a Ca2+-mediated process and NCS-1 has been implicated in short-term synaptic plasticity as well as learning and memory (Gomez et al. 2001). Our study suggests NCS-1 is a Ca2+ sensor that enables TRPC5, via various activating signals at the plasma membrane, to link Ca2+ transients to their effects on growth cone extension. It is therefore proposed that the TRPC5NCS-1 partnership has a role in neuronal development and plasticity perhaps either as a negative feedback mechanism or a mechanism to retard neuronal outgrowth prior to synapse formation.
| Supplemental material |
|---|
|
|
|---|
This material can also be found as part of the full-text HTML version available from http://www.blackwell-synergy.com
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Bahi N, Friocourt G, Carrie A, Graham ME, Weiss JL, Chafey P, Fauchereau F, Burgoyne RD & Chelly J (2003). IL1 receptor accessory protein like, a protein involved in X-linked mental retardation, interacts with Neuronal Calcium Sensor-1 and regulates exocytosis. Hum Mol Genet 12, 14151425.
Bezzerides VJ, Ramsey IS, Kotecha S, Greka A & Clapham DE (2004). Rapid vesicular translocation and insertion of TRP channels. Nat Cell Biol 6, 709720.[CrossRef][Medline]
Bolsover SR (2005). Calcium signalling in growth cone migration. Cell Calcium 37, 395402.[CrossRef][Medline]
Burgoyne RD & Weiss JL (2001). The neuronal calcium sensor family of Ca2+-binding proteins. Biochem J 353, 112.[CrossRef][Medline]
Gomez T (2005). Neurobiology: channels for pathfinding. Nature 434, 835838.[CrossRef][Medline]
Gomez M, De Castro E, Guarin E, Sasakura H, Kuhara A, Mori I, Bartfai T, Bargmann CI & Nef P (2001). Ca2+ signaling via the neuronal calcium sensor-1 regulates associative learning and memory in C. elegans. Neuron 30, 241248.[CrossRef][Medline]
Greka A, Navarro B, Oancea E, Duggan A & Clapham DE (2003). TRPC5 is a regulator of hippocampal neurite length and growth cone morphology. Nat Neurosci 6, 837845.[CrossRef][Medline]
Henley J & Poo MM (2004). Guiding neuronal growth cones using Ca2+ signals. Trends Cell Biol 14, 320330.[CrossRef][Medline]
Kim MT, Kim BJ, Lee JH, Kwon SC, Yeon DS, Yang DK, So I & Kim KW (2006). Involvement of calmodulin and myosin light chain kinase in the activation of mTRPC5 expressed in HEK cells. Am J Physiol Cell Physiol (in press).
Kinoshita-Kawada M, Tang J, Xiao R, Kaneko S, Foskett JK & Zhu MX (2005). Inhibition of TRPC5 channels by Ca2+-binding protein 1 in Xenopus oocytes. Pflugers Arch 450, 345354.[CrossRef][Medline]
Li Y, Jia YC, Cui K, Li N, Zheng ZY, Wang YZ & Yuan XB (2005). Essential role of TRPC channels in the guidance of nerve growth cones by brain-derived neurotrophic factor. Nature 434, 894898.[CrossRef][Medline]
Lin R, Karpa KD, Kabbani N, Goldman-Rakic P & Levenson R (2001). Dopamine D2 and D3 receptors are linked to the actin cytoskelton via interaction with filamin A.. Proc Natl Acad Sci USA 98, 52585263.
McHugh D, Flemming R, Xu SZ, Perraud AL & Beech DJ (2003). Critical intracellular Ca2+ dependence of transient receptor potential melastatin 2 (TRPM2) cation channel activation. J Biol Chem 278, 1100211006.
O'Callaghan DW, Ivings L, Weiss JL, Ashby MC, Tepikin AV & Burgoyne RD (2002). Differential use of myristoyl groups on neuronal calcium sensor proteins as a determinant of spatio-temporal aspects of Ca2+ signal transduction. J Biol Chem 277, 1422714237.
Okada T, Shimizu S, Wakamori M, Maeda A, Kurosaki T, Takada N, Imoto K & Mori Y (1998). Molecular cloning and functional characterization of a novel receptor-activated TRP Ca2+ channel from mouse brain. J Biol Chem 273, 1027910287.
Olafsson P, Soares HD, Herzog KH, Wang T, Morgan JI & Lu B (1997). The Ca2+ binding protein, frequenin is a nervous system-specific protein in mouse preferentially localized in neurites. Brain Res Mol Brain Res 44, 7382.[Medline]
Ordaz B, Tang J, Xiao R, Salgado A, Sampieri A, Zhu MX & Vaca L (2005). Calmodulin and calcium interplay in the modulation of TRPC5 channel activity. Identification of a novel C-terminal domain for calcium/calmodulin-mediated facilitation. J Biol Chem 280, 3078830796.
Plant TD & Schaefer M (2003). TRPC4 and TRPC5: receptor-operated Ca2+-permeable nonselective cation channels. Cell Calcium 33, 441450.[CrossRef][Medline]
Ramsey IS, Delling M & Clapham DE (2006). An introduction to TRP channels. Annu Rev Physiol (in press).
Shim S, Goh EL, Ge S, Sailor K, Yuan JP, Roderick HL, Bootman MD, Worley PF, Song H & Ming GL (2005). XTRPC1-dependent chemotropic guidance of neuronal growth cones. Nat Neurosci 8, 730735.[CrossRef][Medline]
Sossey-Alaoui K, Lyon JA, Jones L, Abidi FE, Hartung AJ, Hane B, Schwartz CE, Stevenson RE & Srivastava AK (1999). Molecular cloning and characterization of TRPC5 (HTRP5), the human homologue of a mouse brain receptor-activated capacitative Ca2+ entry channel. Genomics 60, 330340.[CrossRef][Medline]
Strubing C, Krapivinsky G, Krapivinsky L & Clapham DE (2001). TRPC1 and TRPC5 form a novel cation channel in mammalian brain. Neuron 29, 645655.[CrossRef][Medline]
Strubing C, Krapivinsky G, Krapivinsky L & Clapham DE (2003). Formation of novel TRPC channels by complex subunit interactions in embryonic brain. J Biol Chem 278, 3901439019.
Tang J, Lin Y, Zhang Z, Tikunova S, Birnbaumer L & Zhu MX (2001). Identification of common binding sites for calmodulin and inositol 1,4,5-trisphosphate receptors on the carboxyl termini of Trp channels. J Biol Chem 276, 2130321310.
Voets T, Talavera K, Owsianik G & Nilius B (2005). Sensing with TRP channels. Nat Chem Biol 1, 8592.[CrossRef][Medline]
Waites CL, Craig AM & Garner CC (2005). Mechanisms of vertebrate synaptogenesis. Annu Rev Neurosci 28, 251274.[CrossRef][Medline]
Wang GX & Poo MM (2005). Requirement of TRPC channels in netrin-1-induced chemotropic turning of nerve growth cones. Nature 434, 898904.[CrossRef][Medline]
Weiss JL, Archer DA & Burgoyne RD (2000). Neuronal Ca2+ sensor-1/frequenin functions in an autocrine pathway regulating Ca2+ channels in bovine adrenal chromaffin cells. J Biol Chem 275, 4008240087.
Weiss JL & Burgoyne RD (2002). Sense and sensibility in the regulation of voltage-gated Ca2+ channels. Trends Neurosci 25, 489491.[CrossRef][Medline]
Zeng F, Xu SZ, Jackson PK, McHugh D, Kumar B, Fountain SJ & Beech DJ (2004). Human TRPC5 channel activated by a multiplicity of signals in a single cell. J Physiol 559, 739750.
| Acknowledgements |
|---|
This article has been cited by other articles:
![]() |
K. Hui, G.-H. Fei, B. J. Saab, J. Su, J. C. Roder, and Z.-P. Feng Neuronal calcium sensor-1 modulation of optimal calcium level for neurite outgrowth Development, December 15, 2007; 134(24): 4479 - 4489. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Nichols, A. F. Dengler, E. M. Nakagawa, M. Bashkin, B. T. Paul, J. Wu, and G. M. Khan A Constitutive, Transient Receptor Potential-like Ca2+ Influx Pathway in Presynaptic Nerve Endings Independent of Voltage-gated Ca2+ Channels and Na+/Ca2+ Exchange J. Biol. Chem., December 7, 2007; 282(49): 36102 - 36111. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Gambino, A. Pavlowsky, A. Begle, J.-L. Dupont, N. Bahi, R. Courjaret, R. Gardette, H. Hadjkacem, H. Skala, B. Poulain, et al. IL1-receptor accessory protein-like 1 (IL1RAPL1), a protein involved in cognitive functions, regulates N-type Ca2+-channel and neurite elongation PNAS, May 22, 2007; 104(21): 9063 - 9068. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |